EDITORIAL
Published on 03 Dec 2024
Editorial: Cytochromes P450, their modulators and metabolites in cardiovascular function and disease
doi 10.3389/fphar.2024.1531166
- 283 views
- Frontiers in Pharmacology
- Cardiovascular and Smooth Muscle Pharmacology
- Research Topics
- Cytochrome P450s, Their Modulators, and Metabolites in Cardiovascular Function and Disease
Cytochrome P450s, Their Modulators, and Metabolites in Cardiovascular Function and Disease
1,922
Total downloads
5,984
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 12 Aug 2024
11-Hydroxyeicosatetraenoics induces cellular hypertrophy in an enantioselective manner
doi 10.3389/fphar.2024.1438567
- 510 views
ORIGINAL RESEARCH
Published on 14 Jun 2024
Tetrandrine inhibits aldosterone synthesis by covalently targeting CYP11A1 to attenuate hypertension
doi 10.3389/fphar.2024.1387756
- 734 views
REVIEW
Published on 02 Apr 2024
The involvement of soluble epoxide hydrolase in the development of cardiovascular diseases through epoxyeicosatrienoic acids
doi 10.3389/fphar.2024.1358256
- 1,044 views
- 2 citations
ORIGINAL RESEARCH
Published on 17 Jan 2022
Epoxyeicosatrienoic Acid Analog and 20-HETE Antagonist Combination Prevent Hypertension Development in Spontaneously Hypertensive Rats
doi 10.3389/fphar.2021.798642
- 1,714 views
- 5 citations
Published in
Frontiers in Pharmacology
- Cardiovascular and Smooth Muscle Pharmacology
- Ethnopharmacology
Impact
- 5,984Topic views
- 3,613Article views
- 1,922Article downloads